Similar articles for PMID: 29508728

Year	Number of Results
2008	1
2009	2
2010	2
2011	3
2012	2
2013	6
2014	9
2015	15
2016	29
2017	21
2018	8
2019	3
2020	3
2024	0

1

Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria?

Weinberger M. Weinberger M. Ann Allergy Asthma Immunol. 2018 Mar;120(3):341-342. doi: 10.1016/j.anai.2017.12.018. Ann Allergy Asthma Immunol. 2018. PMID: 29508728 No abstract available.

2

Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria.

Koski R, Kennedy KK. Koski R, et al. Ann Allergy Asthma Immunol. 2017 Nov;119(5):397-401. doi: 10.1016/j.anai.2017.07.029. Ann Allergy Asthma Immunol. 2017. PMID: 29150066 No abstract available.

3

Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.

Vestergaard C, Toubi E, Maurer M, Triggiani M, Ballmer-Weber B, Marsland A, Ferrer M, Knulst A, Giménez-Arnau A. Vestergaard C, et al. Eur J Dermatol. 2017 Feb 1;27(1):10-19. doi: 10.1684/ejd.2016.2905. Eur J Dermatol. 2017. PMID: 27882879 Review.

4

Concomitant treatment with omalizumab and cyclosporine for chronic spontaneous urticaria.

Rosenblum JD, Nassau S, Fonacier L, Mawhirt SL. Rosenblum JD, et al. Ann Allergy Asthma Immunol. 2020 Jul;125(1):111-112. doi: 10.1016/j.anai.2020.04.020. Epub 2020 Apr 29. Ann Allergy Asthma Immunol. 2020. PMID: 32360694 No abstract available.

5

Current challenges and controversies in the management of chronic spontaneous urticaria.

Asero R, Pinter E, Marra AM, Tedeschi A, Cugno M, Marzano AV. Asero R, et al. Expert Rev Clin Immunol. 2015;11(10):1073-82. doi: 10.1586/1744666X.2015.1069708. Epub 2015 Jul 15. Expert Rev Clin Immunol. 2015. PMID: 26174347 Review.

6

Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.

Kulthanan K, Tuchinda P, Chularojanamontri L, Likitwattananurak C, Ungaksornpairote C. Kulthanan K, et al. J Dermatolog Treat. 2017 Mar;28(2):160-165. doi: 10.1080/09546634.2016.1200710. Epub 2016 Jul 7. J Dermatolog Treat. 2017. PMID: 27388043

7

[Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal].

Costa C, Gonçalo M; GPEU – Grupo Português de Estudos de Urticária. Costa C, et al. Acta Med Port. 2016 Nov;29(11):763-781. doi: 10.20344/amp.8294. Epub 2016 Nov 30. Acta Med Port. 2016. PMID: 28229846 Free article. Portuguese.

8

Omalizumab in chronic urticaria.

Metz M, Maurer M. Metz M, et al. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):406-11. doi: 10.1097/ACI.0b013e328355365a. Curr Opin Allergy Clin Immunol. 2012. PMID: 22766620 Review.

9

Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature.

Kasperska-Zajac A, Jarząb J, Żerdzińska A, Bąk K, Grzanka A. Kasperska-Zajac A, et al. Int J Immunopathol Pharmacol. 2016 Jun;29(2):320-8. doi: 10.1177/0394632015623795. Epub 2016 Jan 4. Int J Immunopathol Pharmacol. 2016. PMID: 26729404 Free PMC article.

10

Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.

Metz M, Ohanyan T, Church MK, Maurer M. Metz M, et al. JAMA Dermatol. 2014 Mar;150(3):288-90. doi: 10.1001/jamadermatol.2013.8705. JAMA Dermatol. 2014. PMID: 24477320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year